HB 800Session 2026
Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.
Progress
- Introduced
- In committee
- Passed House
- Passed legislature
- Sent to governor
- Became law
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
Approved by Governor-Chapter 804 (effective 7/1/2026)
-
Governor's Action Deadline 11:59 p.m., April 13, 2026
-
House
Enrolled Bill communicated to Governor on March 10, 2026
-
Senate
Signed by President
-
House
Signed by Speaker
-
House
Fiscal Impact Statement from Department of Planning and Budget (HB800)
-
House
Bill text as passed House and Senate (HB800ER)
-
House
Enrolled
-
Senate
Passed Senate Block Vote (39-Y 0-N 0-A)
-
Senate
Read third time
-
Senate
Passed by for the day
-
Senate
Constitutional reading dispensed Block Vote (on 2nd reading) (38-Y 0-N 0-A)
-
Senate
Rules suspended
-
Senate
Read second time
-
Senate
Reported from Finance and Appropriations (13-Y 0-N)
-
Senate
Referred to Committee on Finance and Appropriations
-
Senate
Constitutional reading dispensed (on 1st reading)
-
House
Read third time and passed House (94-Y 3-N 0-A)
-
House
Read second time and engrossed
-
House
Moved from Uncontested Calendar to Regular Calendar
-
House
Read first time
-
House
Reported from Appropriations (20-Y 0-N)
-
House
Subcommittee recommends reporting (5-Y 0-N)
-
House
Fiscal Impact Statement from Department of Planning and Budget (HB800)
-
House
Assigned HAPP sub: Commerce Agriculture & Natural Resources
-
House
Referred to Committee on Appropriations
-
House
Prefiled and ordered printed; Offered 01-14-2026 26102907D